Cue Biopharma legal chief sells $265,627 in common stock

Sumita Ray, Chief Legal Compliance Officer and Corporate Secretary at Cue Biopharma, sold 8,829 shares of the company's common stock on August 13, 2026, for a total of $265,627. This was after she had purchased 18,196 shares through the exercise of derivative securities. The sales were at prices between $29.37 and $31.13 per share.

These transactions were to cover tax withholding obligations for the vesting and settlement of performance stock units. This is not a discretionary move by Ray. Cue Biopharma's stock surged by 210% over the last six months, which is why these performance-based PSUs are vesting. The company is still considered undervalued according to Fair Value analysis.